利用卷积神经网络及不同输入方案减少MRI钆对比剂用量:合成序列与原始全剂量图像的可互换性有限,尽管定量性能优异
本研究前瞻性纳入138例受试者,采用10%标准剂量钆对比剂后采集低剂量T1w图像,再给剩余90%剂量采集全剂量T1w图像,训练卷积神经网络以非增强和低剂量图像合成人工全剂量T1w图像。定量指标表现良好,但读者研究显示各输入方案合成图像对病灶对比增强的评分均显著低于原始全剂量序列,完全或基本可互换比例最高仅58%,假阳性与假阴性信号导致可互换性显著受限。
要点
- 合成全剂量T1w图像定量指标良好(标准设置PSNR 33.39±0.62 dB,SSIM 0.938±0.005),但阅片可互换性有限。
- 各方案合成图像病灶对比增强评分均显著低于原始全剂量序列(标准设置差-0.97±0.83,P<0.001)。
- 标准、5分钟、扩展、零剂量设置完全或基本可互换比例分别为55%、58%、43%、3%,零剂量方案假阳性最多(2.00±1.07/例)。
核心结论
- 基于仅10%标准剂量钆对比剂后图像合成的T1w全剂量序列定量性能很好,但尽管各设置图像质量良好,假阴性和假阳性信号导致合成序列与原始全剂量序列的可互换性显著受限。
研究设计与样本
- 单中心、机构审查委员会批准的前瞻性研究,共纳入138例参与者,训练样本83例(51.7±16.5岁,36名女性),验证样本25例(55.3±16.4岁,11名女性),测试样本30例(55.0±15.0岁,9名女性);采用给予10%标准剂量钆对比剂后采集T1w低剂量图像、再给予剩余90%标准剂量后采集T1w全剂量图像的改良成像方案,训练深度神经网络合成人工T1w全剂量图像,并设标准、5分钟、扩展、零剂量四种输入设置。
诊断标准与关键数值
- 标准设置合成T1w全剂量图像的峰值信噪比为33.39±0.62(较低剂量序列平均提高5.2 dB),结构相似性指数为0.938±0.005;4折交叉验证中扩展设置峰值信噪比与标准设置相似(P=0.20),结构相似性指数略有提高(P<0.0001)。
临床应用与阅片要点
- 标准、5分钟、扩展、零剂量设置的完全或基本可互换扫描比例分别为55%、58%、43%、3%,每例平均假阳性数分别为0.42±0.83、0.34±0.71、0.82±1.15、2.00±1.07;采用5点Likert量表(0至4分,0为最差),各设置合成全剂量图像病灶对比增强均显著低于原始全剂量序列(平均增强程度差值:标准-0.97±0.83,P<0.001;5分钟-0.93±0.91,P<0.001;扩展-0.96±0.97,P<0.001;零剂量-2.39±1.14,P<0.001),病灶与原始全剂量序列的 conformity 平均评分分别为2.25±1.21、2.22±1.27、2.24±1.25、0.73±0.93。
局限性
- 尽管各设置图像质量良好,假阴性和假阳性信号导致合成序列与原始全剂量序列的可互换性显著受限。
- 原文报告合成全剂量图像病灶对比增强显著低于原始全剂量序列,病灶 conformity 评分未达与原始序列完全一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to implement a state-of-the-art convolutional neural network used to synthesize artificial T1-weighted (T1w) full-dose images from corresponding noncontrast and low-dose images (using various settings of input sequences) and test its performance on a patient population acquired prospectively.
MATERIALS AND METHODS: In this monocentric, institutional review board-approved study, a total of 138 participants were included who received an adapted imaging protocol with acquisition of a T1w low dose after administration of 10% of the standard dose and acquisition of a T1w full dose after administration of the remaining 90% of the standard dose of a gadolinium-containing contrast agent. A total of 83 participants formed the training sample (51.7 ± 16.5 years, 36 women), 25 the validation sample (55.3 ± 16.4 years, 11 women), and 30 the test sample (55.0 ± 15.0 years, 9 women). Four input settings were differentiated: only the T1w noncontrast and T1w low-dose images (standard setting), only the T1w noncontrast and T1w low-dose images with a prolonged postinjection time of 5 minutes (5-minute setting), multiple noncontrast sequences (T1w, T2w, diffusion) and the T1w low-dose images (extended setting), and only noncontrast sequences (T1w, T2w, diffusion) were used (zero-dose setting). For each setting, a deep neural network was trained to synthesize artificial T1w full-dose images, which were assessed on the test sample using an objective evaluation based on quantitative metrics and a subjective evaluation through a reader-based study. Three readers scored the overall image quality, the interchangeability in regard to the clinical conclusion compared with the true T1w full-dose sequence, the contrast enhancement of lesions, and their conformity to the respective references in the true T1w full dose.
RESULTS: Quantitative analysis of the artificial T1w full-dose images of the standard setting provided a peak signal-to-noise ratio of 33.39 ± 0.62 (corresponding to an average improvement of the low-dose sequences of 5.2 dB) and a structural similarity index measure of 0.938 ± 0.005. In the 4-fold cross-validation, the extended setting yielded similar performance to the standard setting in terms of peak signal-to-noise ratio ( P = 0.20), but a slight improvement in structural similarity index measure ( P < 0.0001). For all settings, the reader study found comparable overall image quality between the original and artificial T1w full-dose images. The proportion of scans scored as fully or mostly interchangeable was 55%, 58%, 43%, and 3% and the average counts of false positives per case were 0.42 ± 0.83, 0.34 ± 0.71, 0.82 ± 1.15, and 2.00 ± 1.07 for the standard, 5-minute, extended, and zero-dose setting, respectively. Using a 5-point Likert scale (0 to 4, 0 being the worst), all settings of synthesized full-dose images showed significantly poorer contrast enhancement of lesions compared with the original full-dose sequence (difference of average degree of contrast enhancement-standard: -0.97 ± 0.83, P = <0.001; 5-minute: -0.93 ± 0.91, P = <0.001; extended: -0.96 ± 0.97, P = <0.001; zero-dose: -2.39 ± 1.14, P = <0.001). The average scores of conformity of the lesions compared with the original full-dose sequence were 2.25 ± 1.21, 2.22 ± 1.27, 2.24 ± 1.25, and 0.73 ± 0.93 for the standard, 5-minute, extended, and zero-dose setting, respectively.
CONCLUSIONS: The tested deep learning algorithm for synthesis of artificial T1w full-dose sequences based on images after administration of only 10% of the standard dose of a gadolinium-based contrast agent showed very good quantitative performance. Despite good image quality in all settings, both false-negative and false-positive signals resulted in significantly limited interchangeability of the synthesized sequences with the original full-dose sequences.
引用
- Haase R, Pinetz T, Bendella Z, et al. Reduction of Gadolinium-Based Contrast Agents in MRI Using Convolutional Neural Networks and Different Input Protocols: Limited Interchangeability of Synthesized Sequences With Original Full-Dose Images Despite Excellent Quantitative Performance. Invest Radiol. 2023. PMID: 36735399. doi:10.1097/RLI.0000000000000955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。